Anti-EBAG9

Item number	Size	Datasheet	Manual	SDS	Delivery time	Quantity	Price
NSJ-R31790	100 µg		-	-	3 - 10 business days*		755.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

0.5mg/ml if reconstituted with 0.2ml sterile DI water. Receptor-binding cancer antigen expressed... more

Close menu

Product information "Anti-EBAG9"

0.5mg/ml if reconstituted with 0.2ml sterile DI water. Receptor-binding cancer antigen expressed on SiSo cells is a protein that in humans is encoded by the EBAG9 gene. This gene was identified as an estrogen-responsive gene. Regulation of transcription by estrogen is mediated by estrogen receptor, which binds to the estrogen-responsive element found in the 5'-flanking region of this gene. And the encoded protein is a tumor-associated antigen that is expressed at high frequency in a variety of cancers. Alternate splicing results in multiple transcript variants. A pseudogene of this gene has been defined on chromosome 10. Protein function: May participate in suppression of cell proliferation and induces apoptotic cell death through activation of interleukin-1- beta converting enzyme (ICE)-like proteases. [The UniProt Consortium]

Keywords:	Anti-RCAS1, Anti-EBAG9, Anti-Cancer-associated surface antigen RCAS1, Anti-Receptor-binding cancer antigen expressed on SiSo cells, Anti-Estrogen receptor-binding fragment-associated gene 9 protein, EBAG9 Antibody
Supplier:	NSJ Bioreagents
Supplier-Nr:	R31790

Properties

Application:	WB, IHC (paraffin)
Antibody Type:	Polyclonal
Conjugate:	No
Host:	Rabbit
Species reactivity:	human, mouse, rat
Immunogen:	Amino acids 31-213 of human EBAG9 were used as the immunogen for the EBAG9 antibody.
Format:	Purified